A Phase 3,Double-blinded, Double Dummy, Positive Drug, Parallel, Randomised Controlled Multicenter Trial to Evaluate Efficacy and Safety of Anaprazole Compared With Rabeprazole in Patients With Duodenal Ulcers
Latest Information Update: 10 Jul 2024
At a glance
- Drugs Anaprazole (Primary) ; Rabeprazole
- Indications Duodenal ulcer
- Focus Registrational; Therapeutic Use
- Sponsors Sihuan Pharmaceutical Holdings Group
Most Recent Events
- 14 Feb 2020 According to an Sihuan Pharmaceutical Holdings Group media release, this study will be conducted in about 30 to 45 clinical centres across the PRC. The Study achieved significant progress with the first subject being enrolled in January 2020 after its launch.
- 14 Feb 2020 Status changed from not yet recruiting to recruiting, according to an Sihuan Pharmaceutical Holdings Group media release.
- 04 Feb 2019 New trial record